News | May 11, 2023
Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
The Awards recognizes standout digital health & medical technology products and companies
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Subscribe To Our Newsletter & Stay Updated
